Skip to content
topics.

Trump speeds psychedelic drug research after Oval meeting with Joe Rogan

comedyApr 18, 2026162,459

President Donald Trump signed an executive order on April 18 to fast-track federal review of psychedelics and accelerate research into PTSD and other mental-health treatments. Trump announced the action after a Saturday Oval Office meeting that included podcast host Joe Rogan and Robert F. Kennedy Jr., and Joe Rogan said the White House texted, "Sounds great. Do you want FDA approval? Let’s do it." The order specifically names the controversial drug ibogaine, which has been linked to potentially fatal cardiac events, and directs federal agencies to speed FDA review and expand clinical trial support.

Key Highlights

Trump signed an executive order April 18 to fast-track psychedelics research
Oval Office meeting included Joe Rogan and Robert F. Kennedy Jr.
Order names ibogaine, a controversial drug linked to potentially fatal cardiac events
3 sources
wsj.comHow Joe Rogan Convinced Trump to Fast-Track Review of Psychedelic Drugscnn.comTrump is savaging allies who criticize the Iran war. But he’s treating Joe Rogan very differentlynbclosangeles.app.linkTrump signs order to speed review of psychedelics, including the controversial drug ibogaine

Related

Trump speeds psychedelic drug research after Oval meeting with Joe Rogancomedy